Caspase-3 and Bcl-2 expression in glioblastoma: An immunohistochemical study;Expressão de caspase-3 e Bcl-2 em glioblastomas: Um estudo imunohistoquímico

Arquivos de Neuro-Psiquiatria

Volumn 68, Issue 4, 2010, Pages 603-607

  Tirapelli, Luís Fernando ^a   Bolini, Paulo Henrique Nasser Andre ^a   Tirapelli, Daniela Pretti da Cunha ^a   Peria, Fernanda Maris ^a   Becker, Aline Nazareth Paixão ^a   Saggioro, Fabiano Pinto ^a   Carlotti Júnior, Carlos Gilberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apoptosis; Glioblastoma; Immunohistochemistry

Indexed keywords

CASPASE 3; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; QUANTITATIVE ANALYSIS;

EID: 77957324851     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2010000400023     Document Type: Article

References (20)

1. Collins VP. Cellular mechanisms targeted during astrocytoma progression. Cancer Letters 2002;188:1-7.
2. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO Classification of tu- mours of the central nervous system. Acta Neuropathol 2007;114:97-109.
3. Frei K, Ambar B, Adachi N, Yonekawa Y, Fontana A. Ex vivo malignant glio- ma cells are sensitive to Fas (CD95/APO1) ligant-mediated apoptosis. J Neuroimmunol 1998;87:105-113.
4. Ohgaki H, Kleihues P. Genetic Pathway to primary and secondary glioblasto- ma. Am J Pathol 2007;170:1445-1453.
5. Waltereit R, Weller M. The role of caspases 9 and 9-short (9S) in death ligand- and drug- induced apoptosis in human astrocytoma cells. Mol Brain Res 2002;106:42-49.
6. Riedl SJ, Shi. Y. Molecular mechanism of caspase regulation during apoptosis. Mol Cell Biol 2004;5:897-907.
7. Mao X, Hamouri RA. Molecular and cytogenetic analysis of gliobastoma multiform. Cancer Genet Cytogenet 2000;122:87-92.
8. Prayson RA. Bcl-2 and Bcl-X expression in gangliogliomas. Human Pathol. 1999;30:701-705.
9. Du C, Fang M, Li Y, Li L, Wang X. SMAC, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by elimination IAP inhibition. Cell 2000;102:33-42.
10. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-225.
11. Murphy KM, Ranganathan V, Farnsworth ML, Kavallaris M, Lock RB. Bcl-2 in- hibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ 2000;7:102-111.
12. Metrailler-Ruchonnet I, Pagano A, Carnesecchi S, et al. Bcl-2 protects against hyperoxia-induced apoptosis through inhibition of the mitochondria-dependent pathway. Free Radic Biol Med 2007;42:1062-1074.
13. George J, Banik NL, Ray SK. Bcl-2 siRNA augments taxol mediated apoptot ic death in human glioblastoma U138MG and U251MG cells. Neurochem Res 2009;34:66-78.
14. Lal B, Xia S, Abounader R, Laterra J. Targeting the c-Met pathway potenti- ates glioblastoma responses to gamma-radiation. Clin Cancer Res 2005;11:4479-4486.
15. Martens T, Schmidt NO, Eckerich C, et al. A novel one-armed anti-c-Met- antibody inhibits glioblastoma growth in vivo. Clin Cancer Res 2006;12:6144-6152.
16. Zarnescu O, Brehar FM, Chivu M, Ciurea AV. Immunohistochemical localiza- tion of caspase-3, caspase-9 and Bax in U87 glioblastoma xenografts. J Mol Hist 2008;39:561-569.
17. Bodey B, Bodey V, Siegel SE, et al. Immunocytochemical detection of mem- bers of the caspase cascade of apoptosis in high-grade astrocytomas. In Vivo 2004;18:593-602.
18. Ray SK, Patel SJ, Welsh CT, Wilford G, Hogan EL, Banik NL. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiform: Up regulation of calpain and caspase-3. J Neurosc Res 2002;69:197-206.
19. Yang L, Cao Z, Yan H, Wood WC. Coexistence of high levels of apoptotic sig- naling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003;63:6815-6824.
20. Gdynia G, Grund K, Eckert A, et al. Basal caspase activity promotes migration and invasiveness in glioblastoma cells. Mol Cancer Res 2007;5:1232-1240.